| Literature DB >> 32786131 |
P Cuhna1, B Herlin1, K Vassilev1, A Kas2,3,4, S Lehericy3,4,5, Y Worbe3,6, E Apartis3,4,6, M Vidailhet3,4,7, S Dupont1,3,4,8.
Abstract
Entities:
Keywords: SARS-CoV-2 infection; movement disorders; neurological complications
Mesh:
Year: 2020 PMID: 32786131 PMCID: PMC7436483 DOI: 10.1111/ene.14474
Source DB: PubMed Journal: Eur J Neurol ISSN: 1351-5101 Impact factor: 6.288
Clinical and radiological characteristics of five patients presenting with new onset movement disorder
| Variable | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
|---|---|---|---|---|---|
| Age, years | 51 | 67 | 34 | 66 | 48 |
| Sex | Male | Male | Male | Female | Male |
| Medical history | Disc herniation | Hypertension, poliomyelitis | Hepatitis B healed, typhoid | Hypertension, nephroangio‐sclerosis with severe renal insufficiency stage V, hepatitis B healed | Hypertension, obesity |
| Nasopharyngeal swabs for SARS‐CoV‐2 RNA | Positive | Positive | Positive | Positive | Positive |
| Delay between the onset of symptoms and the diagnosis of SARS‐CoV‐2, days | 9 | 8 | 5 | 11 | 7 |
| ICU | |||||
| Prone positioning | — | Yes | Yes | Yes | Yes |
| Extracorporeal membrane oxygenation procedure (ECMO), days | — | 14 | 9 | — | 18 |
| Tracheotomy, weeks | — | 3 | — | — | — |
| Average length of stay in ICU, days | 12 | 23 | 25 | 19 | 34 |
| Time to neurological presentation after extubation, days | 17 | 31 | 14 | 29 | 24 |
| Average weight loss, kg | 5 | 6 | 15 | 6 | 16 |
| Other complications of SARS‐CoV‐2 infection | Pneumopathy | Pneumopathy | Pneumopathy | Pneumopathy, worsening renal failure requiring dialysis, delirium after extubation requiring haloperidol medication that was rapidly discontinued | Pneumopathy |
| Neurological examination in rehabilitation unit | |||||
| Type of tremor | Action tremor predominant on the right hemibody | Postural and action tremor of upper and lower limbs + orthostatic tremor | Postural and action tremor of the upper limbs | Jerky tremor of the upper limbs | Postural and action tremor of the upper limb |
| Myoclonus | No | Cortical and subcortical | No | Cortical and subcortical | No |
| Pyramidal syndrome | No | No | No | No | No |
| Extrapyramidal syndrome | No | No | No | No | No |
| Motor deficit | Mild global proximal deficit predominating on the right side | Mild right hemiparesis | Mild global proximal deficit | Mild global proximal deficit | Mild proximal belt deficit |
| Critical illness neuropathy | Yes | No | No | No | No |
| Critical illness myopathy | Yes | No | Yes | Yes | Yes |
| Abnormal movement recording | — | Combination of cortical and subcortical myoclonus | — | Combination of cortical and subcortical myoclonus | — |
| MRI | |||||
| Standard MRI | Bilateral frontotemporal hypoperfusion | Corpus callosum microbleeds | Corpus callosum microbleeds | Deep and peripheral microbleeds | Corpus callosum microbleeds |
| Neuromelanin sequence | Loss of visibility of the nigrosomes | Normal | Normal | Normal | Normal |
| DaTScan | Normal | Normal | Normal | Normal | — |
DaTScan, 123I[A1] ‐FP‐CIT SPECT; ICU, intensive care unit; MRI, magnetic resonance imaging.
Figure 1Myoclonus electrophysiology (patients 2 and 4). REW, radial extensor of wrist; RFW, radial flexor of wrist; 1st MI, first interossal muscle; Acc, accelorometer; Trap, trapezius muscle. (a) Surface EMG of right superior member, patient 2: REW, myoclonic bursts of 40–44 ms with 36–44 ms of post‐myoclonic inhibition period (indicated with *); RFW, myoclonic bursts of 24 ms with 66 ms of post‐myoclonic inhibition period (indicated with *); 1st MI, myoclonic bursts of 36 ms with 86 ms of post‐myoclonic inhibition period (indicated with *). (b) Surface EMG of right superior member, patient 4: irregular myoclonic activity on the EMG of trapezius and REW with 70–94 ms of duration of myoclonic bursts. (c) Long loop C reflex with latency of 50 ms recorded from the thenar muscles of patient 4.